Assessment of lipid-lowering therapy prescribing among patients with type 2 Diabetes Mellitus in Malaysian primary care settings
Dyslipidemia is a major contributor to the evolution of cardiovascular disease (CVD) among patients with type 2 diabetes mellitus (T2DM). There is a guideline recommendation to offer statin therapy to all T2DM patients between 40 to 75 years old for either primary or secondary CVD prophylaxis. Never...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
2017
|
| Subjects: | |
| Online Access: | http://irep.iium.edu.my/58961/ http://irep.iium.edu.my/58961/1/20th%20ISPOR%20EURO%20published%20abstract.pdf |
| _version_ | 1848785215124668416 |
|---|---|
| author | Elnaem, Mohamed Hassan Abdelaziz Nik Mohamed, Mohamad Haniki |
| author_facet | Elnaem, Mohamed Hassan Abdelaziz Nik Mohamed, Mohamad Haniki |
| author_sort | Elnaem, Mohamed Hassan Abdelaziz |
| building | IIUM Repository |
| collection | Online Access |
| description | Dyslipidemia is a major contributor to the evolution of cardiovascular disease (CVD) among patients with type 2 diabetes mellitus (T2DM). There is a guideline recommendation to offer statin therapy to all T2DM patients between 40 to 75 years old for either primary or secondary CVD prophylaxis. Nevertheless, the suboptimal management of diabetic dyslipidemia in the Malaysian primary care settings has been reported. This study aimed to describe the statin therapy prescribing pattern among patients with T2DM, evaluate the appropriateness of statin therapy prescribing, and assess the level of achievement of the primary target (LDL-C) for diabetic dyslipidemia treatment. |
| first_indexed | 2025-11-14T16:49:36Z |
| format | Article |
| id | iium-58961 |
| institution | International Islamic University Malaysia |
| institution_category | Local University |
| language | English |
| last_indexed | 2025-11-14T16:49:36Z |
| publishDate | 2017 |
| publisher | International Society for Pharmacoeconomics and Outcomes Research (ISPOR) |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | iium-589612022-07-15T02:34:45Z http://irep.iium.edu.my/58961/ Assessment of lipid-lowering therapy prescribing among patients with type 2 Diabetes Mellitus in Malaysian primary care settings Elnaem, Mohamed Hassan Abdelaziz Nik Mohamed, Mohamad Haniki RM Therapeutics. Pharmacology RM283 Endocrinotheraphy Dyslipidemia is a major contributor to the evolution of cardiovascular disease (CVD) among patients with type 2 diabetes mellitus (T2DM). There is a guideline recommendation to offer statin therapy to all T2DM patients between 40 to 75 years old for either primary or secondary CVD prophylaxis. Nevertheless, the suboptimal management of diabetic dyslipidemia in the Malaysian primary care settings has been reported. This study aimed to describe the statin therapy prescribing pattern among patients with T2DM, evaluate the appropriateness of statin therapy prescribing, and assess the level of achievement of the primary target (LDL-C) for diabetic dyslipidemia treatment. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2017-10-19 Article PeerReviewed application/pdf en http://irep.iium.edu.my/58961/1/20th%20ISPOR%20EURO%20published%20abstract.pdf Elnaem, Mohamed Hassan Abdelaziz and Nik Mohamed, Mohamad Haniki (2017) Assessment of lipid-lowering therapy prescribing among patients with type 2 Diabetes Mellitus in Malaysian primary care settings. Value in Health, 20 (9). A486. ISSN 1098-3015 http://www.valueinhealthjournal.com/article/S1098-3015(17)30831-8/pdf 10.1016/j.jval.2017.08.497 |
| spellingShingle | RM Therapeutics. Pharmacology RM283 Endocrinotheraphy Elnaem, Mohamed Hassan Abdelaziz Nik Mohamed, Mohamad Haniki Assessment of lipid-lowering therapy prescribing among patients with type 2 Diabetes Mellitus in Malaysian primary care settings |
| title | Assessment of lipid-lowering therapy prescribing among patients with type 2 Diabetes Mellitus in Malaysian primary care settings |
| title_full | Assessment of lipid-lowering therapy prescribing among patients with type 2 Diabetes Mellitus in Malaysian primary care settings |
| title_fullStr | Assessment of lipid-lowering therapy prescribing among patients with type 2 Diabetes Mellitus in Malaysian primary care settings |
| title_full_unstemmed | Assessment of lipid-lowering therapy prescribing among patients with type 2 Diabetes Mellitus in Malaysian primary care settings |
| title_short | Assessment of lipid-lowering therapy prescribing among patients with type 2 Diabetes Mellitus in Malaysian primary care settings |
| title_sort | assessment of lipid-lowering therapy prescribing among patients with type 2 diabetes mellitus in malaysian primary care settings |
| topic | RM Therapeutics. Pharmacology RM283 Endocrinotheraphy |
| url | http://irep.iium.edu.my/58961/ http://irep.iium.edu.my/58961/ http://irep.iium.edu.my/58961/ http://irep.iium.edu.my/58961/1/20th%20ISPOR%20EURO%20published%20abstract.pdf |